Previous Article | Next Article ![]()
Journal of Virology, January 2005, p. 1333-1336, Vol. 79, No. 2
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.2.1333-1336.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Cancer Immunology and AIDS,1 Department of Biostatistics, Dana-Farber Cancer Institute,3 Department of Medicine, Harvard Medical School,2 Harvard School of Public Health, Boston, Massachusetts,4 Yerkes National Primate Research Center, Emory University, Atlanta, Georgia5
Received 25 May 2004/ Accepted 3 September 2004
Earlier primate studies revealed that oral transmission of immunodeficiency viruses can occur at all ages [R. M. Ruprecht et al., J. Infect. Dis. 179(Suppl. 3):S408-S412, 1999]. Using a stock of pathogenic simian-human immunodeficiency virus, SHIV89.6P, we compared the 50% animal infectious dose needed to achieve systemic infection after oral challenge in newborn and older infant or juvenile rhesus macaques. Unexpectedly, the older monkeys required a 150-fold-lower virus challenge dose than the neonates (P = 3.3 x 105). In addition, at least 60,000 times more virus was needed to achieve systemic infection in neonates by the oral route than by the intravenous route (P < 1 x 105). Thus, route of inoculation and age are important determinants of SHIV89.6P infectivity in rhesus macaques.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|